| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/04/2009 | US20090142841 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142424 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions |
| 06/04/2009 | US20090142422 An oil-based, nonaqueous herbal extracts of Wrightia tinctoria, Tragia involucrataSali L., and an extract of cocos nucifera (coconut); a pharmaceutical/cosmetic excipients suitable for topical use; eczema, psoriasis and seborrheic dermatitis; nontoxic;side effect reduction; antiinflammatory agents |
| 06/04/2009 | US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 06/04/2009 | US20090142370 Method for preventing skin-cellular aging by using green algae extract and cosmetic composition containing green algae extract |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142301 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
| 06/04/2009 | US20090142295 Anti-Connexin Compounds and Uses Thereof |
| 06/04/2009 | US20090142287 Emulsified antiperspirant composition and method for making same |
| 06/04/2009 | DE112007001469T5 Collagensynthese-Promotor, der Zink als aktiven Bestandteil enthält Contains collagen synthesis promoter, the zinc as an active ingredient |
| 06/04/2009 | CA2707096A1 Composition for treatment and prevention of hair loss and premature graying of hair |
| 06/04/2009 | CA2706656A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | EP2063962A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 06/03/2009 | EP2063879A2 Compositions of chk1 inhibitors and cyclodextrin |
| 06/03/2009 | EP2063859A1 Cosmetic composition for the treatment of skin and methods thereof |
| 06/03/2009 | EP2063851A1 Antimicrobial formulations |
| 06/03/2009 | EP1959972A4 Method of treating open wounds using hypochlorous acid |
| 06/03/2009 | EP1863469A4 A topical analgesic composition |
| 06/03/2009 | EP1807062A4 Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
| 06/03/2009 | EP1575533B1 Topical compositions having a natural ingredient and method of use |
| 06/03/2009 | EP1435906B1 Method for producing biologically active products |
| 06/03/2009 | EP1399472B1 Soluble heterodimeric cytokine receptor |
| 06/03/2009 | EP1313737B1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | CN101444519A Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/03/2009 | CN101444470A Use of oligosaccharides to stimulate beta-endorphin production |
| 06/03/2009 | CN100494361C Skin cell with anti-inflammatory activity, and its preparing method and use for skin infective wound surface |
| 06/03/2009 | CN100494205C Phosphorylated glyceryl ether aluminium salts |
| 06/03/2009 | CN100493617C Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof |
| 06/03/2009 | CN100493606C Use of human lysozyme in preparing medicines for cutaneous pruritus |
| 06/03/2009 | CN100493551C Chinese medicine composition for inhibiting tyrosinase activity and use thereof |
| 06/03/2009 | CN100493513C Application of 4-de-dimethyltetracycline derivative |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541354 Bicyclo-pyrazoles |
| 06/02/2009 | US7541047 Method for production of shaped body for treating wounds in milk producing animals |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541027 polyclonal antibodies, monoclonal antibodies, F(ab')2, Fab and single chain Fv; tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor |
| 06/02/2009 | CA2434277C Substituted alkylamine derivatives and methods of use |
| 06/02/2009 | CA2229010C Mannose-6-phosphate analogues for the treatment of wounds and fibrotic disorders with reduced scarring |
| 05/28/2009 | WO2009067081A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/28/2009 | WO2009066775A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same |
| 05/28/2009 | WO2009066283A2 Calcium-mediated effects of coral and methods of use thereof |
| 05/28/2009 | WO2009065946A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 05/28/2009 | WO2009065854A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/28/2009 | WO2009065787A1 Use of amorolfine for treating a nail disease by iontophoresis |
| 05/28/2009 | WO2009065226A1 Modulation of tdag51 to inhibit scar formation in skin wound healing and internal organ fibrosis |
| 05/28/2009 | WO2009010968A3 Disease treatment via antimicrobial peptides or their inhibitors |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137631 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137569 Administration of (3S)-N-hydroxy-4-(sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (S)-N_hydroxy-4-[4_(but-2-ynyloxy)phenylsulfonyl]-2,2-dimethyl thimomorpholine-3-carboxamide for preventing and/or treating inflammatory skin pathologies/afflictions |
| 05/28/2009 | US20090137534 Skin treatment compositions and methods |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137497 Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine |
| 05/28/2009 | US20090137475 Medicaments and proteins based on tgf-beta monomers for the treatment of wounds |
| 05/28/2009 | US20090137465 Novel use |
| 05/28/2009 | US20090137453 Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof |
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090136604 Bacterial extracts cultured in thermal waters for treating sensitive skin, mucous membranes and scalps |
| 05/28/2009 | US20090136511 an oligopeptide capable of binding cellular IL-15R alpha or its soluble fraction and inhibiting IL-15-dependent T cell proliferation activity, used for treating rheumatoid arthritis and psoriasis in a mammal; immunogens |
| 05/28/2009 | US20090136430 Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis |
| 05/28/2009 | DE102007056424A1 Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion A pharmaceutical composition containing an oil / water emulsion |
| 05/28/2009 | DE102007056253A1 Use of homogenized sloe composition, obtained by heating, e.g. for liquefaction of body fluids, reduction of surface tension, for the reduction of body odor, preferably excrement and sweat, to promote hair growth and as antibiotic |
| 05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 05/28/2009 | CA2705599A1 New compounds |
| 05/28/2009 | CA2705596A1 New compounds |
| 05/28/2009 | CA2705405A1 New compounds |
| 05/28/2009 | CA2704883A1 New compounds |
| 05/28/2009 | CA2704882A1 Use of amorolfine for treating a nail disease by iontophoresis |
| 05/28/2009 | CA2704214A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/27/2009 | EP2062895A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 05/27/2009 | EP2062889A1 Compounds |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062588A1 Composition for amelioration of skin condition |
| 05/27/2009 | EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 05/27/2009 | EP2061811A2 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 05/27/2009 | EP2061749A1 Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate |
| 05/27/2009 | EP2061470A2 Haloalkyl-substituted pyrimidinone derivatives |
| 05/27/2009 | EP2061451A2 Bis(thiohydrazide amides) for treating melanoma |
| 05/27/2009 | EP1981874B1 Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 05/27/2009 | EP1877095B1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 05/27/2009 | EP1694627B1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 05/27/2009 | EP1548032B1 Kdr peptides and vaccines comprising the same |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1485080B1 Use of adapalene for the treatment of dermatological disorders |
| 05/27/2009 | EP1408045B1 Novel galactosylceramide analogs and beta-glucocerebrosidase activators,external skin preparations and method of activating beta-glucocerebrosidase using the analogs |